Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Petersen

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Clinical Cardiology|September 16, 2021
Association of coronary microvascular dysfunction and cardiac bridge integrator 1, a cardiomyocyte dysfunction biomarkerChristine Pacheco, Janet Wei, Chrisandra Shufelt, et al.
American Heart Journal|February 26, 2025
Rationale and design of the women's ischemia syndrome evaluation mechanisms of coronary microvascular dysfunction leading to preheart failure with preserved ejection fraction (WISE Pre-HFPEF)Tatsunori Takahashi, Janet Wei, Ana C Iribarren, et al.
American Heart Journal Plus : Cardiology Research and Practice|April 4, 2025
Intracoronary acetylcholine for vasospasm provocation in women with ischemia and no obstructive coronary artery diseaseBenita Tjoe, Christine Pacheco, Nissi Suppogu, et al.
International Journal of Cardiology|November 17, 2020
Left ventricular circumferential strain and coronary microvascular dysfunction: A report from the Women's Ischemia Syndrome Evaluation Coronary Vascular Dysfunction (WISE-CVD) ProjectBalaji Tamarappoo, T Jake Samuel, Omeed Elboudwarej, et al.
European Heart Journal. Imaging Methods and Practice|July 24, 2024
Pericardial late gadolinium enhancement and time to recurrence: a substudy from RHAPSODY, a phase 3 clinical trial of rilonacept in recurrent pericarditisPaul C Cremer, David Lin, Sushil A Luis, et al.
Nature Communications|February 25, 2016
Specifically modified Env immunogens activate B-cell precursors of broadly neutralizing HIV-1 antibodies in transgenic miceAndrew T McGuire, Matthew D Gray, Pia Dosenovic, et al.
JACC. Cardiovascular Interventions|June 23, 2012
Safety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) studyJanet Wei, Puja K Mehta, B Delia Johnson, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 8, 2020
Coronary Vascular Function and Cardiomyocyte Injury: A Report From the WISE-CVDAhmed AlBadri, Janet Wei, Odayme Quesada, et al.
Journal of the American Heart Association|February 18, 2020
Angina Hospitalization Rates in Women With Signs and Symptoms of Ischemia But no Obstructive Coronary Artery Disease: A Report from the WISE (Women's Ischemia Syndrome Evaluation) StudyHaider Aldiwani, Melody Zaya, Nissi Suppogu, et al.
American Heart Journal|December 30, 2019
Design, methodology and baseline characteristics of the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD)Odayme Quesada, Ahmed AlBadri, Janet Wei, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Clinical Cardiology|September 16, 2021
Association of coronary microvascular dysfunction and cardiac bridge integrator 1, a cardiomyocyte dysfunction biomarkerChristine Pacheco, Janet Wei, Chrisandra Shufelt, et al.
American Heart Journal|February 26, 2025
Rationale and design of the women's ischemia syndrome evaluation mechanisms of coronary microvascular dysfunction leading to preheart failure with preserved ejection fraction (WISE Pre-HFPEF)Tatsunori Takahashi, Janet Wei, Ana C Iribarren, et al.
American Heart Journal Plus : Cardiology Research and Practice|April 4, 2025
Intracoronary acetylcholine for vasospasm provocation in women with ischemia and no obstructive coronary artery diseaseBenita Tjoe, Christine Pacheco, Nissi Suppogu, et al.
International Journal of Cardiology|November 17, 2020
Left ventricular circumferential strain and coronary microvascular dysfunction: A report from the Women's Ischemia Syndrome Evaluation Coronary Vascular Dysfunction (WISE-CVD) ProjectBalaji Tamarappoo, T Jake Samuel, Omeed Elboudwarej, et al.
European Heart Journal. Imaging Methods and Practice|July 24, 2024
Pericardial late gadolinium enhancement and time to recurrence: a substudy from RHAPSODY, a phase 3 clinical trial of rilonacept in recurrent pericarditisPaul C Cremer, David Lin, Sushil A Luis, et al.
Nature Communications|February 25, 2016
Specifically modified Env immunogens activate B-cell precursors of broadly neutralizing HIV-1 antibodies in transgenic miceAndrew T McGuire, Matthew D Gray, Pia Dosenovic, et al.
JACC. Cardiovascular Interventions|June 23, 2012
Safety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) studyJanet Wei, Puja K Mehta, B Delia Johnson, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 8, 2020
Coronary Vascular Function and Cardiomyocyte Injury: A Report From the WISE-CVDAhmed AlBadri, Janet Wei, Odayme Quesada, et al.
Journal of the American Heart Association|February 18, 2020
Angina Hospitalization Rates in Women With Signs and Symptoms of Ischemia But no Obstructive Coronary Artery Disease: A Report from the WISE (Women's Ischemia Syndrome Evaluation) StudyHaider Aldiwani, Melody Zaya, Nissi Suppogu, et al.
American Heart Journal|December 30, 2019
Design, methodology and baseline characteristics of the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD)Odayme Quesada, Ahmed AlBadri, Janet Wei, et al.
Pageof 4